NextTrip, Inc. (NTRP) - Dilution Analysis

S-3 filing: This filing relates to the resale of 537,894 shares of common stock by selling stockholders, consisting of shares issuable upon conversion of Series B preferred stock and exercise of warrants.

8-K filing: The Company issued and sold 368,421 Series B Convertible Preferred Shares plus 40,000 additional Series B Preferred Shares as an issuance fee and a five-year warrant to purchase 100,000 shares of Common Stock at a purchase price of $2.7550 per share.

10-Q filing | 13.7M shares outstanding

S-3 filing: This prospectus relates to the resale or other disposition from time to time by the selling stockholder named in this prospectus of up to 2,000,000 shares of our common stock.

8-K filing: NextTrip, Inc. completed a private placement offering on December 23, 2025, issuing 1,000,000 shares of common stock and warrants to purchase an additional 1,000,000 shares, resulting in gross proceeds of approximately $3,000,000. ($3.0M proceeds)

S-3/A filing: Nexttrip, Inc. files an S-3/A form to offer up to $75,000,000 of any combination of common stock, preferred stock, and debt securities.

S-3 filing: NextTrip, Inc. files an S-3 registration statement to offer and sell up to $75,000,000 of any combination of common stock, preferred stock, and debt securities from time to time.

10-Q filing | 7.9M shares outstanding

8-K filing: NextTrip, Inc. converted $152,970 of debt from two independent directors, Carmen Diges and Stephen Kircher, into 47,803 restricted shares of Series Q Preferred Stock at $3.20 per share, retroactive to September 3, 2025. ($0.15M proceeds)

8-K filing: NextTrip, Inc. consummated the sale of 81,250 shares of Series Q Nonvoting Convertible Preferred Stock at a price of $3.20 per share on September 15, 2025. ($0.26M proceeds)

S-1/A filing: This prospectus relates to the resale or other disposition from time to time, in one or more offerings, by the selling stockholders named in this prospectus of up to 591,883 shares of our common stock

S-1/A filing: This S-1/A filing relates to the resale of up to 591,883 shares of common stock by selling stockholders.

10-Q filing | 7.8M shares outstanding

S-1 filing: This prospectus relates to the resale or other disposition from time to time, in one or more offerings, by the selling stockholders named in this prospectus of up to 2,366,056 shares of our common stock.

10-K filing | 7.7M shares outstanding

8-K filing: On May 5, 2025, the Company issued 1,450,000 Contingent Shares to the NextTrip Sellers, completing the issuance of all Contingent Shares under the Exchange Agreement.

8-K filing: NextTrip, Inc. issued an aggregate of 129,032 shares of Series O Nonvoting Convertible Preferred Stock as Milestone Payments to FSA Members on April 28, 2025, in accordance with the terms of the Membership Interest Purchase Agreement.

RW filing: The Company is seeking withdrawal of the Registration Statement because it opted not to pursue the offering contemplated thereby.

8-K filing: NextTrip, Inc. entered into a securities purchase agreement with Alumni Capital LP for the sale of a short-term promissory note and warrants for $300,000.

8-K filing: The Company issued a total of 176,794 shares of common stock from January 10, 2025, through March 7, 2025, and rescheduled its 2025 Annual Meeting for April 9, 2025. ($0.68M proceeds)

8-K filing: NextTrip, Inc. consummated a series of securities transactions, issuing 341,126 restricted shares of Series I Convertible Preferred Stock at $3.02 per share on February 24, 2025. ($1.03M proceeds)

8-K filing: The Company and Blue Fysh Holdings Inc. entered into a share exchange agreement whereby Blue Fysh agreed to issue 117 restricted shares of its common stock to the Company in exchange for 483,000 restricted shares of Series N Nonvoting Convertible Preferred Stock of the Company at an issuance price of $5.00 per share. ($2.42M proceeds)

8-K filing: Designation of 451,614 shares of Series O Convertible Preferred Stock with specific rights related to dividends, voting, conversion, and liquidation.

8-K filing: NextTrip, Inc. entered into Amendment No. 1 to Forbearance Agreement, extending the Forbearance Expiration Date to March 31, 2025, and issued 17,000 shares of Series N Nonvoting Convertible Preferred Stock and warrants to purchase 17,000 shares of common stock at $5.00 per share and Warrant. The company also filed a Certificate of Designation for Series N Convertible Preferred Stock, designating 500,000 shares. ($0.09M proceeds)

10-Q filing | 1.6M shares outstanding

8-K filing: NextTrip, Inc. consummated a series of separate securities transactions, including the issuance and sale of Series J, K, L, and M Nonvoting Convertible Preferred Stock. ($0.9M proceeds)

S-1/A filing: NextTrip, Inc. is filing an S-1/A to register shares of common stock, pre-funded warrants, and common warrants for a firm commitment public offering.

10-Q filing | 1.4M shares outstanding

8-K filing: NextTrip, Inc. sold an additional 66,225 shares of Series I Preferred on October 2, 2024, and 4,967 and 24,834 shares on August 15 and August 30, 2024, respectively, at $3.02 per share, raising aggregate gross proceeds of $290,000.

S-1/A filing: NextTrip, Inc. is filing an S-1/A registration statement for a firm commitment public offering of shares of its common stock and warrants to purchase shares of its common stock.

8-K filing: NextTrip, Inc. entered into a securities purchase agreement with Alumni Capital LP for the sale of a short-term promissory note and warrants for $250,000 and also has the right but not the obligation to have Alumni Capital LP purchase up to $10 million of Common Stock.

10-Q filing | 1.3M shares outstanding

10-K filing | 1.4M shares outstanding

S-1 filing: NextTrip, Inc. is conducting a firm commitment public offering of common stock, pre-funded warrants, and common warrants.

8-K filing: Sigma Additive Solutions, Inc. completed a sale of securities, issuing $672,500 of securities consisting of 222,680 restricted shares of Series I Convertible Preferred Stock and warrants to purchase up to 111,340 shares of common stock to accredited investors at a combined price of $3.02 per share of Series I Preferred and one-half warrant. ($0.67M proceeds)

8-K filing: Sigma Additive Solutions, Inc. completed the acquisition of NextTrip Holdings, Inc., sold assets to Divergent Technologies, Inc., and sold shares of common stock under its at-the-market agreement in October 2023. ($0.77M proceeds)

8-K filing: Sigma Additive Solutions, Inc. issued 100,000 restricted shares of Series G Convertible Preferred Stock to Promethean TV, Inc. and filed certificates of designation for Series G and Series H Convertible Preferred Stock.

8-K filing: Sigma Additive Solutions, Inc. filed a Certificate of Designation of Series F Convertible Preferred Stock, designating 5,843,993 shares of preferred stock as Series F Convertible Preferred Stock in connection with its acquisition of NextTrip Holdings, Inc.

10-Q filing | 0.8M shares outstanding

8-K filing: Sigma Additive Solutions, Inc. entered into a Share Exchange Agreement with NextTrip Holdings, Inc. to acquire NextTrip in exchange for shares of Sigma's common stock, with additional shares contingent upon NextTrip's achievement of future business milestones, and is subject to shareholder approval.

8-K filing: Stock split 1-for-20 | Outstanding: 10,772,713 → 538,635

10-Q filing | 10.8M shares outstanding

10-Q filing | 10.7M shares outstanding

S-3/A filing: The filing relates to the offer and sale from time to time by the selling stockholders of up to 1,265,896 shares of our common stock issuable upon the exercise of outstanding common stock purchase warrants.

10-K filing | 10.5M shares outstanding

S-3 filing: This prospectus relates to the offer and sale from time to time by the selling stockholders of up to 1,265,896 shares of our common stock issuable upon the exercise of outstanding common stock purchase warrants sold and issued by us in an April 2020 private placement.

8-K filing: Sigma Additive Solutions, Inc. agreed to issue a warrant to purchase up to 225,000 shares of common stock and the company furloughed several of its workforce to conserve cash.

10-Q filing | 10.5M shares outstanding

10-Q filing | 10.5M shares outstanding

10-Q filing | 10.5M shares outstanding

10-K filing | 10.5M shares outstanding

10-Q filing | 10.5M shares outstanding

10-Q filing | 10.5M shares outstanding

S-3 filing: Sigma Labs, Inc. is filing an S-3 to offer and sell up to $50,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants, and units.

S-3 filing: This prospectus relates to the offer and sale from time to time of up to 2,602,143 shares of our common stock issuable upon the exercise of currently outstanding common stock purchase warrants by selling stockholders.

10-Q filing | 6.0M shares outstanding

8-K filing: Sigma Labs, Inc. completed a registered direct offering and a concurrent private placement on March 26, 2021, issuing 2,190,000 shares of common stock at $4.445 per share and warrants to purchase 2,190,000 shares at an exercise price of $4.32 per share, with gross proceeds of $9,734,550 before deducting fees. ($9.73M proceeds)

10-K filing | 1.4M shares outstanding

8-K filing: Sigma Labs, Inc. completed an underwritten public offering of 1,711,783 shares of common stock at $3.00 per share, with net proceeds of approximately $4,532,444, and issued warrants to purchase 100,000 shares of common stock as consideration for a waiver. ($5.14M proceeds)

10-Q filing | 5.8M shares outstanding

8-K filing: Sigma Labs, Inc. issued 1,895,049 shares of common stock upon the exercise of Preferred Warrants and the subsequent conversion of Preferred Shares, resulting in gross proceeds of $3,478,800. ($3.48M proceeds)

10-Q filing | 3.9M shares outstanding

S-3 filing: This prospectus relates to the offer and sale from time to time of up to 515,465 shares of our common stock issuable upon the exercise of currently outstanding common stock purchase warrants.

8-K filing: On April 6, 2020, the Company closed a public offering of equity securities in which it issued 493,027 shares of common stock and pre-funded warrants to purchase up to 22,438 shares of common stock and also issued Series A Warrants to purchase an aggregate of 515,465 shares of the Company's common stock pursuant to a private placement resulting in gross proceeds of $1,500,000. Additionally, between March 27, 2020 and June 9, 2020, the company received aggregate gross proceeds of $2,141,100 from exercises of warrants to purchase Series D Preferred Stock issued in our January 28, 2020 financing. ($3.0M proceeds)

10-Q filing | 1.8M shares outstanding

8-K filing: Sigma Labs, Inc. entered into a Securities Purchase Agreement to sell and issue 515,465 units consisting of common stock or prefunded warrants and Series A warrants in a public offering and private placement for $2.91 per unit, with net proceeds expected to be approximately $1,230,000. ($1.23M proceeds)

10-K filing | 0.9M shares outstanding

8-K filing: Stock split 1-for-10 | Outstanding: 14,037,590 → 1,403,759

S-3/A filing: This S-3/A filing relates to an offering of common stock by selling stockholders. The company will not receive any proceeds from the sale of the common stock but may receive proceeds from the exercise of warrants.

S-3 filing: This S-3 filing includes information on common stock offered by selling stockholders, with 121,704,222 shares being offered and 14,037,590 shares outstanding as of February 3, 2020. The company will not receive any proceeds from the sale of the common stock offered hereby.

8-K filing: Sigma Labs, Inc. entered into Securities Purchase Agreements with institutional investors and other investors for the issuance and sale of Series D and Series E Convertible Preferred Stock, warrants to purchase Common Stock, and warrants to purchase Series D Preferred Stock. ($2.1M proceeds)